Premium Nahrungsergänzungsmittel | artgerecht

Beta Trace Protein – Biomarker for Kidney & CSF

Beta Trace Protein (BTP) is an endogenous protein found in cerebrospinal fluid and blood, used as a biomarker for kidney function assessment and detection of cerebrospinal fluid leaks.

Regular tips about health Regular tips about health

Things worth knowing about "Beta Trace Protein"

Beta Trace Protein (BTP) is an endogenous protein found in cerebrospinal fluid and blood, used as a biomarker for kidney function assessment and detection of cerebrospinal fluid leaks.

What is Beta Trace Protein?

Beta Trace Protein (BTP), also known as lipocalin-type prostaglandin D synthase, is a small protein produced primarily in the cerebrospinal fluid (CSF) by cells of the central nervous system. It enters the bloodstream in small quantities and is subsequently filtered and excreted by the kidneys. Due to these characteristics, BTP serves as a valuable biomarker in two key medical areas: kidney function diagnostics and the detection of CSF leaks.

Biological Function

Beta Trace Protein belongs to the lipocalin protein family and functions as an enzyme that catalyzes the conversion of prostaglandin H2 into prostaglandin D2. Prostaglandin D2 is involved in regulating the sleep-wake cycle and inflammatory responses within the central nervous system. BTP has a relatively low molecular weight of approximately 23–29 kDa, which allows it to be efficiently filtered by healthy kidneys.

Clinical Significance as a Kidney Function Marker

Because Beta Trace Protein passes freely through the glomerular filter of the kidney and is then completely reabsorbed and metabolized, its serum concentration rises when the glomerular filtration rate (GFR) declines. BTP is therefore considered a sensitive marker for reduced kidney function.

BTP can detect reduced kidney function at an early stage, often before classical markers such as creatinine show significant changes.
It is particularly useful in patient groups where creatinine-based estimations are unreliable, such as children, elderly individuals, patients with very low or high body weight, or those with altered muscle mass.
Research indicates that BTP used in combination with other markers such as cystatin C can improve the accuracy of GFR estimation.

Clinical Significance in the Detection of CSF Leaks

Since Beta Trace Protein is present in very high concentrations in the cerebrospinal fluid (approximately 35 times higher than in blood serum), it can serve as a marker for the presence of CSF in body fluids where it does not normally occur.

A CSF leak (CSF fistula) occurs when the protective membranes surrounding the brain or spinal cord are damaged, for example following head trauma, neurosurgical procedures, or spontaneously.
The detection of BTP in nasal fluid (rhinorrhea) or ear fluid (otorrhea) can indicate CSF leakage into these areas.
BTP is considered a reliable and practical marker for this purpose and is used clinically as an alternative to beta-2 transferrin.

Diagnosis and Measurement

Beta Trace Protein levels are typically measured using immunonephelometry or immunoturbidimetry from a blood or CSF sample. Reference values in adult serum generally range between 0.4 and 1.2 mg/l, though this may vary depending on the laboratory and measurement method used.

Elevated serum levels indicate impaired kidney function.
Elevated levels in nasal or ear secretions suggest a cerebrospinal fluid leak.
In newborns and children, BTP values are naturally higher than in adults, so age-specific reference ranges must be applied.

Advantages and Limitations

As a biomarker, BTP offers several advantages: it is not significantly influenced by muscle mass, diet, or physical activity, making it more reliable than creatinine in many patient populations. However, there are also limitations to consider:

BTP levels can be elevated in certain neurological conditions, such as meningitis or following a stroke, independently of kidney function.
In patients receiving corticosteroid therapy, BTP levels may be reduced, which can complicate interpretation.
The measurement method is not yet as widely standardized as creatinine testing.

References

Filler G, Bokenkamp A, Hofmann W, et al. - Cystatin C as a marker of GFR – history, indications, and future research. Clinical Biochemistry, 2005.
Priem F, Althaus H, Birnbaum M, et al. - Beta-trace protein in serum: a new marker of glomerular filtration rate in the creatinine-blind range. Clinical Chemistry, 1999; 45(4):567–568.
Arrer E, Meco C, Oberascher G, et al. - Beta-trace protein as a marker for cerebrospinal fluid rhinorrhea. Clinical Chemistry, 2002; 48(6):939–941.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.